Prevention of Rh sensitization in the context of trauma: two case reports.

abstract：:The combined use of immunoadsorption (IA) and membrane filtration (MF) may markedly enhance removal of IgM and complement component C1q, supporting its use as an element of recipient desensitization in antibody-incompatible transplantation. However, coagulation factor removal may contribute to altered hemostasis, posi...

journal_title：Journal of clinical apheresis

authors： Biesenbach P,Eskandary F,Ay C,Wiegele M,Derfler K,Schaden E,Haslacher H,Oberbauer R,Böhmig GA

更新日期：2016-02-01 00:00:00

abstract：:Since the introduction of hematopoietic growth factors, the collection of mobilized stem cells via leukapheresis has widely replaced the harvest of bone marrow in both autologous and allogeneic transplantation settings. We investigated the frequency and the extent of anticoagulant-induced electrolyte changes and the c...

journal_title：Journal of clinical apheresis

authors： Schlenke P,Frohn C,Steinhardt MM,Kirchner H,Klüter H

更新日期：2000-01-01 00:00:00

abstract：:Although rituximab (RTX) is a promising therapeutic agent for treating steroid-resistant nephrotic syndrome (SRNS) resistant to various immunosuppressive agents, some patients have shown resistance to RTX. We report the case of a patient with RTX-resistant nephrotic syndrome and SRNS who was successfully treated with ...

journal_title：Journal of clinical apheresis

authors： Takakura M,Shimizu M,Mizuta M,Inoue N,Tasaki Y,Ohta K,Furuichi K,Wada T,Yachie A

更新日期：2018-06-01 00:00:00

abstract：:Sickle cell disease (SCD) patients are prone to develop complications that include stroke, acute chest syndrome, and other crises. Some of these complications require chronic transfusion therapy or red cell exchange (RCE), either for therapeutic or prophylactic reasons. Due to a discrepancy of red cell antigens betwee...

journal_title：Journal of clinical apheresis

authors： Sarode R,Altuntas F

更新日期：2006-12-01 00:00:00

abstract：:An improved method for intermittent-flow erythrocytapheresis in patients with sickle cell disease is reported. The method, a modification of the standard red cell exchange procedure for the Haemonetics 30S unit, dilutes with physiologic saline the patient's blood as it flows from the draw line and before it reaches th...

journal_title：Journal of clinical apheresis

authors： Castro O,Finke-Castro H,Coats D

更新日期：1986-01-01 00:00:00

abstract：:Because the administration of hematopoietic growth factors and the use of stem cell support often fails to alleviate the neutropenic phase induced by cytotoxic drugs, several investigators have attempted to expand ex vivo hematopoietic progenitors for clinical use. These attempts have clearly shown that the cultured c...

journal_title：Journal of clinical apheresis

authors： Estrov Z,Huh YO,Ginsberg CF,Harris D,Van Q,Mirza NQ,Talpaz M,Korbling M

更新日期：2002-01-01 00:00:00

abstract：BACKGROUND:Autologous stem cell transplantation (auto-SCT) is a treatment approach in non-Hodgkin lymphoma (NHL) patients. The options for mobilization of CD34+ cells to support high-dose therapy are granulocyte-colony stimulating factors (G-CSFs) alone or after chemotherapy. Limited data exist on the efficacy of lipeg...

journal_title：Journal of clinical apheresis

authors： Partanen A,Turunen A,Valtola J,Vasala K,Ågren L,Penttilä K,Pyörälä M,Kuittinen T,Mäntymaa P,Pelkonen J,Jantunen E,Varmavuo V

更新日期：2020-08-01 00:00:00

abstract：:Plerixafor in combination with granulocyte-colony stimulating factor (G-CSF) is approved for autologous stem cell mobilization in poor mobilizing patients with multiple myeloma or malignant lymphoma. The purpose of this study was to evaluate efficacy and safety of plerixafor in an immediate rescue approach, administra...

journal_title：Journal of clinical apheresis

authors： Worel N,Fritsch G,Agis H,Böhm A,Engelich G,Leitner GC,Geissler K,Gleixner K,Kalhs P,Buxhofer-Ausch V,Keil F,Kopetzky G,Mayr V,Rabitsch W,Reisner R,Rosskopf K,Ruckser R,Zoghlami C,Zojer N,Greinix HT

更新日期：2017-08-01 00:00:00

abstract：:Mobilized PBSC are the main source for allogeneic HSCT. We aimed to evaluate factors that affect CD34+ cell yield including the donor's age, gender, BSA, processed blood volume and the method of G-CSF dose calculation. Data from 170 healthy donors were analyzed. The concentration of CD34+ cells in the peripheral blood...

journal_title：Journal of clinical apheresis

authors： Machaczka M,Hägglund H,Staver E,Joks M,Hassan M,Wahlin BE,Axdorph Nygell U

更新日期：2017-12-01 00:00:00

abstract：:Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease treated successfully with plasma exchange. Jehovah's Witnesses whose religious beliefs preclude them from accepting plasma exchange may require alternative forms of therapy. We report a case of one such patient who presented with TTP, whom we succ...

journal_title：Journal of clinical apheresis

authors： Dabak V,Kuriakose P,Raman S

更新日期：2007-01-01 00:00:00

abstract：:The infusion of high-dose (275 mg/kg body weight) immune globulin intravenous (IGIV) after 466 plasma exchanges in 64 patients with autoimmune disease was studied. Side effects occurred during 15% of IGIV infusions. For the most part they were transient and mild, and could be controlled by slowing the infusion rate. T...

journal_title：Journal of clinical apheresis

authors： Dau PC

更新日期：1983-01-01 00:00:00

abstract：INTRODUCTION:Limited data are available describing indications for and outcomes of therapeutic plasma exchange (TPE) in cardiac transplantation. METHODS:In a retrospective study of patients who underwent cardiac transplantation at Duke University Medical Center from 2010 to 2014, we reviewed 3 TPE treatment patterns: ...

journal_title：Journal of clinical apheresis

authors： Onwuemene OA,Grambow SC,Patel CB,Mentz RJ,Milano CA,Rogers JG,Metjian AD,Arepally GM,Ortel TL

更新日期：2018-08-01 00:00:00

abstract：:The process of publishing original work in a peer review journal is not complete at the point where the manuscript is first submitted. The journal editors will submit the manuscript to peer review whereby outside experts are asked to vet the manuscript for scientific merit, originality and quality. Reviewers' comments...

journal_title：Journal of clinical apheresis

authors： Weinstein R

更新日期：2020-08-07 00:00:00

abstract：OBJECTIVE:Effects of therapeutic plasma exchange (TPE) on immune cells and their cytokine production in MS, are unknown. Since interleukine-6 and tumor growth factor-β have critical roles in MS immunopathogenesis, the impacts of TPE on the expression of these cytokines and their receptors on the surface of CD4+ T lymph...

journal_title：Journal of clinical apheresis

authors： Jamshidian A,Abd-Nikfarjam B,Khademi Z,Shaygannejad V,Salehi M

更新日期：2020-04-01 00:00:00

abstract：:The removal of specific antibody in experimental animals has been reported to result in a subsequent increase in antibody to levels equal to (rebound) or exceeding those existing prior to removal (overshoot). Anecdotal reports suggest that rebound antibody synthesis after plasmapheresis may occur in humans with autoim...

journal_title：Journal of clinical apheresis

authors： Nasca TJ,Muder RR,Thomas DB,Schrecker JC,Ruben FL

更新日期：1990-01-01 00:00:00

abstract：:The issues of providing quality blood products and maintaining donor safety are primary aims of blood transfusion services. A comprehensive quality system should be in place to fulfill these aims, which can be attained through strict adherence to the established standard operating procedures (SOPs). The Drugs and Cosm...

journal_title：Journal of clinical apheresis

authors： Chaudhary R,Sekhar Das S,Agarwal P,Shanker Shukla J

更新日期：2005-07-01 00:00:00

abstract：BACKGROUND:Currently, low titer A plasma is used on a routine basis in bleeding trauma patients of unknown AB type. Three AB non-bleeding apheresis patients are presented here who safely received a combination of AB and low titer A plasma during therapeutic plasma exchange (TPE). One control AB patient received AB plas...

journal_title：Journal of clinical apheresis

authors： Kaplan A,Sevcik J,Kiss JE

更新日期：2019-02-01 00:00:00

abstract：INTRODUCTION:ABO- or HLA-incompatible kidney transplantation is possible thanks to pretransplant antibody-depletion achieved by extracorporeal-treatment modalities. These methods induce depletion of some plasma proteins and may also impact on proteins involved in hemostasis. METHODS:To determine the impact of one sess...

journal_title：Journal of clinical apheresis

authors： Marlu R,Bennani HN,Seyve L,Malvezzi P,Janbon B,Noble J,Christophe M,Motte L,Imerzoukene F,Chevallier E,Rostaing L,Jouve T

更新日期：2020-08-17 00:00:00

abstract：:This study examined the incidence and predictors of peripheral blood stem cell (PBSC) mobilization failure in patients with multiple myeloma (MM). Retrospective data for 104 patients who received granulocyte colony-stimulating factor (G-CSF) alone or with cyclophosphamide as mobilization regimens were analyzed. The ra...

journal_title：Journal of clinical apheresis

authors： Jung SH,Yang DH,Ahn JS,Kim YK,Kim HJ,Lee JJ

更新日期：2014-12-01 00:00:00

abstract：:Transfusion-acquired babesiosis can be an asymptomatic or self-limited febrile hemolytic illness in a healthy host. A persistent, relapsing, and/or fulminant course with the development of life-threatening complications may be seen in immunocompromised or splenectomized patients. As in malaria, erythrocyte parasitemia...

journal_title：Journal of clinical apheresis

authors： Herman JH,Ayache S,Olkowska D

更新日期：2010-01-01 00:00:00

abstract：:Bone marrow (BM) damage after previous chemotherapy, such as that involving alkylating agents, and radiation therapy alone cannot explain poor hematopoietic progenitor cell mobilization. We examined the T lymphocytes of BM in 67 autologous peripheral blood stem cell transplant (auto-PBSCT) patients with non-Hodgkin ly...

journal_title：Journal of clinical apheresis

authors： Oka S,Nohgawa M

更新日期：2020-07-28 00:00:00

abstract：:Peripheral blood stem cells (PBSC) reinfusion appears to hasten hematologic reconstitution following myeloablative therapy. While procurement of PBSC adds apheresis procedures, rapid engraftment could decrease the demand for platelet transfusions. To determine the impact of PBSC collection on workload in our apheresis...

journal_title：Journal of clinical apheresis

authors： Ghalie R,McLeod B,Richman C,Valentino L,Manson S,Netols C,Kaizer H

更新日期：1992-01-01 00:00:00

abstract：:Staphylococcal protein A efficiently binds immunoglobulins and circulating immune complexes (CIC) and provides an effective medium to remove immunoglobulins and CICs from plasma while sparing albumin and most coagulation proteins. Although it activates the complement system its clinical use abrogates the need for plas...

journal_title：Journal of clinical apheresis

authors： Howe RB,Christie DJ

更新日期：1994-01-01 00:00:00

abstract：BACKGROUND AND OBJECTIVES:Specialized centers claim a need for blood component production independent from the general blood transfusion services. We performed a prospective change control analysis of the transfer of platelet (PLT) production for hematological patients at the University Hospital Basel from the Departme...

journal_title：Journal of clinical apheresis

authors： Sigle JP,Medinger M,Stern M,Infanti L,Heim D,Halter J,Gratwohl A,Buser A

更新日期：2012-01-01 00:00:00

abstract：:The literature on the use of therapeutic apheresis is often criticized for the preponderance of low to very low quality evidence. Shehata et al. examined the apheresis literature published between 1976 and 1999 and found a lack of randomized controlled trials with those identified demonstrating significant limitations...

journal_title：Journal of clinical apheresis

authors： Winters JL

更新日期：2013-02-01 00:00:00

abstract：:Extra-corporeal photopheresis (ECP) is known as safe ultimate treatment option for chronic lung allograft dysfunction (CLAD). Here, we report the first case of ECP as "second-line" immunomodulatory therapy early post-transplant in an adult patient undergoing lung transplantation for severe chronic thromboembolic pulmo...

journal_title：Journal of clinical apheresis

authors： Steinack C,Robinson CA,Nägeli M,Inci I,Benden C

更新日期：2020-08-24 00:00:00

abstract：:Prestorage leukocyte reduction of platelet concentrates may reduce adverse effects of transfusion while affording better quality control. Platelets and leukocytes may undergo activation during storage, which could affect the performance of leukocyte reduction filters. The purpose of this study was to evaluate the effi...

journal_title：Journal of clinical apheresis

authors： Jin YS,Mintz PD

更新日期：1997-01-01 00:00:00

abstract：BACKGROUND:Plasma exchange (PE) and double filtration plasmapheresis (DFPP) are known as effective treatment options for hyperviscosity syndrome (HVS) caused by Waldenstrom macroglobulinemia. Nonetheless, few data are available for the relation between the prescribed dose of apheresis and the reduction rate of target m...

journal_title：Journal of clinical apheresis

authors： Miyamoto Y,Hamasaki Y,Matsumoto A,Doi K,Noiri E,Nangaku M

更新日期：2018-10-01 00:00:00

abstract：:We describe the case of a 24 year old male with severe fistulating Crohn's disease who failed mutliple modalities of medical and surgical therapy. We present objective and subjective evidence of disease remission after induction and maintenance treatment with leukocyte apheresis. This is the first described case of su...

journal_title：Journal of clinical apheresis

authors： Tate D,Cairnes V,Valori R,Makins R

更新日期：2014-06-01 00:00:00

abstract：:We sought to optimize direct intravenous infusion of calcium gluconate (CaGlu) for maintaining plasma ionized calcium concentration ([Ca2+ ]) and preventing hypocalcemic reactions during 34 consecutive 1-volume therapeutic plasma exchanges (TPEs) in eight patients. CaGlu, 2 g in 50 mL of 0.9% NaCl, was prepared by our...

journal_title：Journal of clinical apheresis

authors： Zhao Y,Garrity D,Graves M,Linden J,St Pierre P,Ducharme P,Greene M,Vauthrin M,Weinstein R

更新日期：2019-12-01 00:00:00